IL26 and asthma: Similarly, lung fibroblasts release IL-26 in response to endotoxin via MAPK, NF-κB, and TRIF-dependent pathways, which are inhibited by asthma and COPD therapies such as hydrocortisone, salbutamol, and tiotropium [61].